Email this article THE RELATIONSHIP OF SERUM LEPTIN AND PLASMA APELIN LEVELS IN MEN WITH METABOLIC SYNDROME
- Authors: Fedotova A.V.1, Chernysheva E.N.1, Panova T.N.1, Akhtyamova K.V.1
-
Affiliations:
- Astrakhan State Medical University
- Issue: Vol 44, No 4 (2016)
- Pages: 457-461
- Section: ARTICLES
- URL: https://almclinmed.ru/jour/article/view/435
- DOI: https://doi.org/10.18786/2072-0505-2016-44-4-457-461
- ID: 435
Cite item
Full Text
Abstract
Background: The metabolic syndrome is seen as a cluster of high cardiovascular risk factors. New hormone-like substances, such as adipokines leptin and apelin, produced by fat tissue, are important for the pathophysiology of the metabolic syndrome.
Aim: To evaluate levels of plasma apelin and serum leptin in patients with metabolic syndrome.
Materials and methods: We examined 122 male patients with metabolic syndrome and 30 healthy males aged from 25 to 60 years. All patients were assessed accordingly to confirm the diagnosis of the metabolic syndrome, with additional measurements of serum leptin and plasma apelin.
Results: Serum leptin levels were 10-fold higher and plasma apelin levels 3-fold higher in patients with metabolic syndrome (n=122), compared to the controls (n=30): 25.43 vs. 3.99 ng/mL (p<0.05) and 1.13 vs. 0.66 ng/mL (p<0.05), respectively. Serum leptin levels correlated with all parameters of the excess body weight, such as body mass (r=0.79, р<0.05), body mass index (r=0.93, р<0.05), waist circumference (r=0.61, р<0.05), hip circumference (r=0.57, р<0.05), and waist-to-hip ratio (WHR; r=0.4, р<0.05). Plasma apelin levels correlated with the waist circumference (r=0.27, р<0.05) and WHR (r=0.29, р<0.05). There was a significant increase of serum leptin dependent on the bodyweight category: 19.8 ng/mL in patients with obesity Grade I (n=49) and 28.7 ng/mL in those with obesity Grade II (n=46) (р<0.05). There was a non-significant trend towards an increase in plasma apelin depending on bodyweight. As far as abdominal obesity is concerned, in patients with WHR<1 (n=35), plasma apelin level was 0.36 ng/mL, whereas in those with WHR of ≥1 (n=87), it was 3-fold higher (1.09 ng/mL, р<0.05); the increase in serum leptin levels was non-significant. There was no association between plasma apelin and serum leptin in patients with metabolic syndrome (r=0.1, р>0.05).
Conclusion: The adipokine levels in men with metabolic syndrome are higher than in normal men. Serum leptin level is a sensitive parameter indicating accumulation of the fat tissue, irrespective of its localization. Plasma apelin is less sensitive, but it does reflect fat accumulation of the central (abdominal) type.
Keywords
About the authors
A. V. Fedotova
Astrakhan State Medical University
Author for correspondence.
Email: fedotova_alena_v@mail.ru
Postgraduate Student, Chair of Hospital Therapy,
39/10–69 M. Maksakova ul., Astrakhan, 414056,
121 Bakinskaya ul., Astrakhan, 414000
Russian FederationE. N. Chernysheva
Astrakhan State Medical University
Email: fake@neicon.ru
MD, PhD, Associate Professor, Chair of Hospital Therapy,
121 Bakinskaya ul., Astrakhan, 414000
Russian FederationT. N. Panova
Astrakhan State Medical University
Email: fake@neicon.ru
MD, PhD, Professor, Chair of Hospital Therapy,
121 Bakinskaya ul., Astrakhan, 414000
Russian FederationK. V. Akhtyamova
Astrakhan State Medical University
Email: fake@neicon.ru
Postgraduate Student, Chair of Hospital Therapy,
121 Bakinskaya ul., Astrakhan, 414000
Russian FederationReferences
- Boucher J, Masri B, Daviaud D, Gesta S, Guigné C, Mazzucotelli A, Castan-Laurell I, Tack I, Knibiehler B, Carpéné C, Audigier Y, Saulnier-Blache JS, Valet P. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology. 2005;146(4):1764–71. doi: 10.1210/en.2004-1427.
- Szokodi I, Tavi P, Földes G, Voutilainen-Myllylä S, Ilves M, Tokola H, Pikkarainen S, Piuhola J, Rysä J, Tóth M, Ruskoaho H. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res. 2002;91(5):434–40.
- Romantsova TI, Volkova GE. Leptin i grelin: antagonism i vzaimodeystvie v regulyatsii energeticheskogo obmena [Leptin and ghrelin: their antagonism and interplay in the regulation of energy turnover]. Ozhirenie i metabolizm [Obesity and Metabolism]. 2005;(2):2–9 (in Russian).
- Yue P, Jin H, Xu S, Aillaud M, Deng AC, Azuma J, Kundu RK, Reaven GM, Quertermous T, Tsao PS. Apelin decreases lipolysis via G(q), G(i), and AMPK-Dependent Mechanisms. Endocrinology. 2011;152(1):59–68. doi: 10.1210/en.2010-0576.
- Chazova IE, Mychka VB, Kislyak OA, Kuznetsova IV, Litvin AYu, Shestakova MV, Bugrova SA, Zvenigorodskaya LA, Koshel'skaya OA, Kukharchuk VV, Mamedov MN, Medvedeva IV, Mkrtumyan AM, Nebieridze DV, Nedogoda SV, Perepech' NB, Podzolkov VI, Simonova GI, Titov VN, Tyurina TV, Fursov AN, Khirmanov VN, Chukaeva II, Shal'nova SA, Shubina AT. Diagnostika i lechenie metabolicheskogo sindroma. Rossiyskie rekomendatsii (vtoroy peresmotr) [The diagnosis and treatment of the metabolic syndrome. The Russian guidelines, 2nd review]. Kardiovaskulyarnaya terapiya i profilaktika [Cardiovascular Therapy and Prevention]. 2009;8(6 Suppl 2):1–29 (in Russian).
Supplementary files
